Manufacturing system development for scaling advanced therapies
Readying your groundbreaking therapy production processes to tackle commercial scale manufacture.
We partner with advanced therapy developers to translate the complexities and nuances of advanced therapies production processes into closed and automated manufacturing-ready systems. We work alongside your PD and manufacturing teams to co-develop GMP-compliant processes that benefit from scalability, cost-effectiveness, and throughput, while preserving the biological functionality and process innovations that give your therapies their competitive edge.
Our approach reduces development risk, shortens timelines, and accelerates scalable delivery of cell and gene therapies to patients, giving biotech leaders a greater chance of succeeding in a competitive market.
Where your cutting-edge biology meets scalable engineering
Integrated expertise in cell and gene therapy manufacturing processes
Our teams bring together deep biological insight and advanced engineering to design and build systems that elevate the commercial-readiness of your products, aligning with your technical and regulatory requirements. We specialise in providing systems that work with your biology, rather than having to adapt to the constraints of off-the-shelf tools.
Manufacturing systems inspired by your process
We don’t have a catalogue of devices to sell to you. Instead, we want manufacturing strategy to be led by your biology. We take the time to understand and collaborate with your development teams, agreeing an approach - blending established kits with custom design - to deliver sustained benefits, making your operations more efficient and reproducible, adding robustness to your process development more and preparing your company for GMP manufacturing at scale.
Accelerate to patients and scale with confidence
By considering your product from all angles, from process alignment, regulatory compliance, and scale-up from day one, we help you avoid common development setbacks that slow others down. Our approach enables smoother biotech process development and creates a clearer path to GMP process readiness and commercial success.
Patient-driven partnerships designed for long-term impact
Every process we help enable is better suited to reduce the cost of goods, accelerate delivery timelines, and improve consistency, while maintaining safety and efficacy at scale. Our work is guided by long-term commercial viability and patient access, not just speed to clinical trial.
Speak to an advanced therapies expert today.
TTP has been an incredible partner, complementing our expertise and delivering designs from white board to moulded functional prototypes. With TTP’s support, Achilles is scaling our manufacturing process and bringing transformative therapies from bench to bedside. The TTP team has shown the same level of excitement as us in getting these therapies to the people who need them.
Ed Samuel
EVP Technical Operations
The system, potentially the largest undertaking in biotech manufacturing automation, required 25 man-years to develop and incorporates over 1 million components. While a significant investment, it’s noteworthy that its cost was less than a single day's EPO revenue.
Stephen Fleck
LabTech
Supporting biotech leaders in therapy commercialisation
We collaborate with forward-thinking biotech companies developing:
- Emerging therapies that challenge standard manufacturing process
- Cell and gene therapies requiring novel analytics integration
- Therapies in transition from early stage to GMP manufacturing
- Autologous, allogeneic, and personalised medicine categories
If you’re seeking a partner to co-develop a tailored solution, we align your biology, process, and commercial goals to build the right manufacturing process for your therapy.
Speak to an advanced therapies expert today.
Scaling the future of advanced therapies
Biotech leaders know the science is no longer the critical bottleneck - scaling is. Delivering advanced therapies to thousands, even hundreds of thousands of patients, demands new approaches on automation, digitalisation, supply chains, regulation, and partnerships.
This exclusive report distils the insights of industry pioneers into 11 clear priorities every biotech executive should understand to stay ahead. From building digital-ready manufacturing to unlocking investment and government support, it’s a practical roadmap for leaders who need to drive growth and patient access.
Download the report and see how the most forward-thinking leaders are preparing for the next era of biotech.
Creating strategic advantage through scalable biotech manufacturing
Our approach enables you to move faster without compromising scientific or operational integrity. By aligning our development approach with your biology and leveraging process closure and automation, we reduce technical risk and cost of goods while supporting long-term manufacturing scale.
The result is more than clinical success; it’s a differentiated cell and gene therapy manufacturing platform that sets your company apart in a competitive market and get therapies to patients, fast.
Speak to an advanced therapies expert today.
How we can help
Co-developing bespoke manufacturing systems to run GMP-compliant processes
We collaborate to architect custom process closure and automation platforms that reflect your cell-specific or vector-specific process requirements. We use GMP-compliant equipment design processes so that you can qualify these systems with confidence, and successfully integrate upstream and downstream operations for autologous, allogeneic, or novel personalised medicine categories.
Accommodating biological complexity in engineered process control systems
We specialise in converting from manual, cumbersome, or sensitive process steps into scalable, automatable unit operations. Our cross-functional teams bridge immunology, cell biology, and synthetic biology with mechatronics, fluidics, and embedded systems to enable higher process consistency and, ultimately, repeatable, closed-loop control of your bioprocess.
Accelerating IND-enabling and GMP-scale development
From lab-scale proof-of-concept to technology transfer and clinical manufacturing, we design automation processes that reduce operator dependence, mitigate contamination risks, and improve batch consistency. We incorporate sensor integration, data capture, and traceability to support QbD and regulatory submission readiness.
Reducing cost of goods through intelligent system design
We create architectures for single-use consumables, walk-away hardware, and process monitoring that reduce the stresses on manual interventions, consumable use, and cleanroom demands. We focus on modular, scalable design, enabling cost-efficient manufacture while preserving the flexibility required for evolving therapy pipelines.
Providing technical leadership in bioprocess system development
Beyond execution, we act as technical collaborators. We bring domain expertise across flow control, sterile interfacing, robotics, control logic, and device integration, helping you de-risk critical decisions around process architecture, automation strategy, and GMP system validation.
Co-developing bespoke manufacturing systems to run GMP-compliant processes
We collaborate to architect custom process closure and automation platforms that reflect your cell-specific or vector-specific process requirements. We use GMP-compliant equipment design processes so that you can qualify these systems with confidence, and successfully integrate upstream and downstream operations for autologous, allogeneic, or novel personalised medicine categories.
Accommodating biological complexity in engineered process control systems
We specialise in converting from manual, cumbersome, or sensitive process steps into scalable, automatable unit operations. Our cross-functional teams bridge immunology, cell biology, and synthetic biology with mechatronics, fluidics, and embedded systems to enable higher process consistency and, ultimately, repeatable, closed-loop control of your bioprocess.
Accelerating IND-enabling and GMP-scale development
From lab-scale proof-of-concept to technology transfer and clinical manufacturing, we design automation processes that reduce operator dependence, mitigate contamination risks, and improve batch consistency. We incorporate sensor integration, data capture, and traceability to support QbD and regulatory submission readiness.
Reducing cost of goods through intelligent system design
We create architectures for single-use consumables, walk-away hardware, and process monitoring that reduce the stresses on manual interventions, consumable use, and cleanroom demands. We focus on modular, scalable design, enabling cost-efficient manufacture while preserving the flexibility required for evolving therapy pipelines.
Providing technical leadership in bioprocess system development
Beyond execution, we act as technical collaborators. We bring domain expertise across flow control, sterile interfacing, robotics, control logic, and device integration, helping you de-risk critical decisions around process architecture, automation strategy, and GMP system validation.
Our approach and capabilities
We deliver across the entire life of a project, from opportunity discovery to production engineering. Discover how our interdisciplinary teams of experts collaborate to tackle the toughest product development challenges.
Our campus and facilities
Our award-winning campus has been designed with a clear vision. To create a space which can support our people and our clients as we develop and deliver the very best technology solutions.
Meet some of the team
Stuart Lowe
Tom Broughton
Douglas Bradshaw
Talk to us about your next project
We help clients with all stages of their most complex and challenging technology and product development projects.
If you're considering the next steps along your innovation journey, why not get in touch?